ELIAS ANIMAL HEALTH LLC

Capabilities

ELIAS Animal Health, a medical biotechnology company, is conducting clinical trials on and commercializing a novel targeted T cell-based immunotherapy (ELIAS Cancer Immunotherapy) for the treatment of cancer in the veterinary sector. The company’s proprietary (and patented) therapeutic approach offers the potential for improved clinical outcomes, low toxicity and fundamentally changing the way cancer is treated in the companion animal market. The company's product is distributed under 9 CFR 103.3 to veterinarians treating companion animals for certain cancer types.